Trial designed to investigate the cardioprotective properties of CardiolRx(TM) in patients hospitalized with COVID-19 who have a prior history of, or risk factors for, cardiovascular disease...
The first pharmaceutically produced THC-free* extra-strength cannabidiol (CBD) Oakville, Ontario–(Newsfile Corp. – October 20, 2020) – Cardiol Therapeutics Inc. (TSX: CRDL) (OTCQX: CRTPF) (“Cardiol” or the...
Trial will take place at major U.S. centers and examine the cardioprotective properties of CardiolRx(TM) in patients hospitalized with COVID-19 who have a prior history of,...
Oakville, Ontario–(Newsfile Corp. – September 15, 2020) – Cardiol Therapeutics Inc. (TSX: CRDL) (OTCQX: CRTPF) (“Cardiol” or the “Company“), a leader in the development of pharmaceutical...
Study Designed to Support Cardiol Therapeutics’ Phase 2 International Trial in Acute Myocarditis Oakville, Ontario–(Newsfile Corp. – August 26, 2020) – Cardiol Therapeutics Inc. (TSX: CRDL)...
Oakville, Ontario–(Newsfile Corp. – June 29, 2020) – Cardiol Therapeutics Inc. (TSX: CRDL) (OTCQX: CRTPF) (“Cardiol” or the “Company“), a leader in the production of pharmaceutical...
Oakville, Ontario–(Newsfile Corp. – June 4, 2020) – Cardiol Therapeutics Inc. (TSX: CRDL) (“Cardiol” or the “Company“), a leader in the production of pharmaceutical cannabidiol (CBD)...
Oakville, Ontario–(Newsfile Corp. – June 2, 2020) – Cardiol Therapeutics Inc. (TSX: CRDL) (OTCQX: CRTPF) (“Cardiol” or the “Company“), a leader in the production of pharmaceutical...
Oakville, Ontario–(Newsfile Corp. – May 29, 2020) – Cardiol Therapeutics Inc. (TSX: CRDL) (OTCQX: CRTPF) (“Cardiol” or the “Company“), a leader in the production of pharmaceutical cannabidiol...
Oakville, Ontario–(Newsfile Corp. – May 14, 2020) – Cardiol Therapeutics Inc. (TSX: CRDL) (OTCQX: CRTPF) (“Cardiol” or the “Company“), a leader in the production of pharmaceutical cannabidiol...